Brand Name

Miglitol

View Brand Information
FDA approval date: January 15, 2021
Classification: alpha-Glucosidase Inhibitor
Form: Tablet

What is Miglitol?

Miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome: A Case Report.
Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: February 23, 2026
Evaluation of novel topiramate-phenolic acid conjugates as potent pancreatic α-amylase inhibitors: in vitro and in silico insights.
Evaluation of novel topiramate-phenolic acid conjugates as potent pancreatic α-amylase inhibitors: in vitro and in silico insights.
Journal: Journal of computer-aided molecular design
Published: December 17, 2025
TAS2R38 taster variants-linked MGAM expression in Alzheimer's disease: a novel target for precision drug repurposing.
TAS2R38 taster variants-linked MGAM expression in Alzheimer's disease: a novel target for precision drug repurposing.
Journal: Frontiers in aging neuroscience
Published: December 15, 2025
View All Latest Advances